정밀의료 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Precision Medicine Market size is expected to reach USD 386.16 Billion in 2034 from USD 93.06 Billion (2025) growing at a CAGR of 17.13% during 2026-2034.

The precision medicine market is experiencing rapid growth, driven by advancements in genomics, biotechnology, and data analytics that enable tailored treatment approaches for individual patients. As healthcare shifts towards personalized care, the demand for precision medicine solutions is increasing, particularly in oncology, where targeted therapies are revolutionizing cancer treatment. The integration of genetic testing and biomarker identification is allowing healthcare providers to develop customized treatment plans that optimize therapeutic efficacy and minimize adverse effects. This trend is expected to propel the market forward, as patients and providers alike seek more effective and individualized healthcare solutions.

Innovations in technology and data management are also shaping the future of the precision medicine market. The rise of artificial intelligence and machine learning is enhancing the ability to analyze complex datasets, leading to improved patient stratification and treatment outcomes. Additionally, advancements in bioinformatics are facilitating the integration of genomic data into clinical practice, enabling healthcare providers to make informed decisions based on a patient's unique genetic profile. As these technologies continue to evolve, the market is likely to witness a diversification of precision medicine applications across various therapeutic areas, including rare diseases and chronic conditions.

Moreover, the precision medicine market will benefit from increased investment in research and development, as pharmaceutical companies and healthcare organizations recognize the potential of personalized therapies. Collaborative efforts between academic institutions, industry stakeholders, and regulatory bodies will be crucial in advancing clinical trials and ensuring the successful implementation of precision medicine strategies. As the landscape evolves, the focus will shift towards integrating precision medicine into standard care pathways, emphasizing the importance of multidisciplinary approaches in delivering optimal patient outcomes.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Technology

• Bioinformatics
• Big Data Analytics
• Drug Discovery
• Gene Sequencing
• Companion Diagnostics
• Others

By Application

• CNS
• Immunology
• Oncology
• Respiratory
• Others

By End-Use

• Diagnostic Companies
• Pharmaceutical Companies
• Healthcare IT companies
• Others
• Sequencing by Synthesis
• Ion Semiconductor Sequencing
• Sequencing by Ligation
• Pyrosequencing
• Single Molecule Real Time Sequencing
• Chain Termination Sequencing
• Nanopore Sequencing

By Product

• Consumables
• Instruments
• Services

By Route of Administration

• Oral
• Injectable

By Drugs

• Alectinib
• Osimertinib
• Mepolizumab
• Aripiprazole Lauroxil
• Others

COMPANIES PROFILED

• Biocrates Life Sciences, Tepnel Pharma Services, Novartis, Qiagen, Quest Diagnostics, Menarini Silicon Biosystems, NanoString Technologies, Eagle Genomics, Pfizer, Intomics, Roche, Teva Pharmaceutical

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL PRECISION MEDICINE MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Technology
• 4.2. Bioinformatics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Big Data Analytics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Drug Discovery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Gene Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Companion Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PRECISION MEDICINE MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. CNS Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Immunology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Respiratory Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PRECISION MEDICINE MARKET: BY END-USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-use
• 6.2. Diagnostic Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Pharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Healthcare IT companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PRECISION MEDICINE MARKET: BY SEQUENCING BY SYNTHESIS 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Sequencing By Synthesis
• 7.2. Ion Semiconductor Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL PRECISION MEDICINE MARKET: BY SEQUENCING BY LIGATION 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast Sequencing By Ligation
• 8.2. Pyrosequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Single Molecule Real Time Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Chain Termination Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.5. Nanopore Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL PRECISION MEDICINE MARKET: BY PRODUCT 2022-2034 (USD MN)

• 9.1. Market Analysis, Insights and Forecast Product
• 9.2. Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.3. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.4. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 10. GLOBAL PRECISION MEDICINE MARKET: BY ROUTE OF ADMINISTRATION 2022-2034 (USD MN)

• 10.1. Market Analysis, Insights and Forecast Route Of Administration
• 10.2. Oral Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 10.3. Injectable Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 11. GLOBAL PRECISION MEDICINE MARKET: BY DRUGS 2022-2034 (USD MN)

• 11.1. Market Analysis, Insights and Forecast Drugs
• 11.2. Alectinib Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 11.3. Osimertinib Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 11.4. Mepolizumab Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 11.5. Aripiprazole Lauroxil Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 11.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 12. GLOBAL PRECISION MEDICINE MARKET: BY REGION 2022-2034(USD MN)

• 12.1. Regional Outlook
• 12.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 12.2.1 By Technology
  • 12.2.2 By Application
  • 12.2.3 By End-use
  • 12.2.4 By Sequencing By Synthesis
  • 12.2.5 By Sequencing By Ligation
  • 12.2.6 By Product
  • 12.2.7 By Route Of Administration
  • 12.2.8 By Drugs
  • 12.2.9 United States
  • 12.2.10 Canada
  • 12.2.11 Mexico
• 12.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 12.3.1 By Technology
  • 12.3.2 By Application
  • 12.3.3 By End-use
  • 12.3.4 By Sequencing By Synthesis
  • 12.3.5 By Sequencing By Ligation
  • 12.3.6 By Product
  • 12.3.7 By Route Of Administration
  • 12.3.8 By Drugs
  • 12.3.9 United Kingdom
  • 12.3.10 France
  • 12.3.11 Germany
  • 12.3.12 Italy
  • 12.3.13 Russia
  • 12.3.14 Rest Of Europe
• 12.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 12.4.1 By Technology
  • 12.4.2 By Application
  • 12.4.3 By End-use
  • 12.4.4 By Sequencing By Synthesis
  • 12.4.5 By Sequencing By Ligation
  • 12.4.6 By Product
  • 12.4.7 By Route Of Administration
  • 12.4.8 By Drugs
  • 12.4.9 India
  • 12.4.10 Japan
  • 12.4.11 South Korea
  • 12.4.12 Australia
  • 12.4.13 South East Asia
  • 12.4.14 Rest Of Asia Pacific
• 12.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 12.5.1 By Technology
  • 12.5.2 By Application
  • 12.5.3 By End-use
  • 12.5.4 By Sequencing By Synthesis
  • 12.5.5 By Sequencing By Ligation
  • 12.5.6 By Product
  • 12.5.7 By Route Of Administration
  • 12.5.8 By Drugs
  • 12.5.9 Brazil
  • 12.5.10 Argentina
  • 12.5.11 Peru
  • 12.5.12 Chile
  • 12.5.13 South East Asia
  • 12.5.14 Rest of Latin America
• 12.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 12.6.1 By Technology
  • 12.6.2 By Application
  • 12.6.3 By End-use
  • 12.6.4 By Sequencing By Synthesis
  • 12.6.5 By Sequencing By Ligation
  • 12.6.6 By Product
  • 12.6.7 By Route Of Administration
  • 12.6.8 By Drugs
  • 12.6.9 Saudi Arabia
  • 12.6.10 UAE
  • 12.6.11 Israel
  • 12.6.12 South Africa
  • 12.6.13 Rest of the Middle East And Africa

Chapter 13. COMPETITIVE LANDSCAPE

• 13.1. Recent Developments
• 13.2. Company Categorization
• 13.3. Supply Chain & Channel Partners (based on availability)
• 13.4. Market Share & Positioning Analysis (based on availability)
• 13.5. Vendor Landscape (based on availability)
• 13.6. Strategy Mapping

Chapter 14. COMPANY PROFILES OF GLOBAL PRECISION MEDICINE INDUSTRY

• 14.1. Top Companies Market Share Analysis
• 14.2. Company Profiles
  • 14.2.1 Biocrates Life Sciences
  • 14.2.2 Tepnel Pharma Services
  • 14.2.3 Novartis
  • 14.2.4 Qiagen
  • 14.2.5 Quest Diagnostics
  • 14.2.6 Menarini Silicon Biosystems
  • 14.2.7 NanoString Technologies
  • 14.2.8 Eagle Genomics
  • 14.2.9 Pfizer
  • 14.2.10 Intomics
  • 14.2.11 Roche
  • 14.2.12 Teva Pharmaceutical